Is TECH Overvalued?

TECH is now in the Undervalued zone, suggesting that TECH current forward PE ratio of 29.44 is considered Undervalued compare with the five-year average of 44.77.
P/E
EV/EBITDA
P/S
P/B
bubble
P/E

TECH Competitors Valuation Multiple

P/E
EV/EBITDA
P/S

P/E Multiple

Earnings Growth
Market Cap
stocks logo
TECH.O
Bio-Techne Corp
29.44
Average P/E: 33.28
26.59%
9.83B
stocks logo
TLX.O
Telix Pharmaceuticals Ltd
72.38
11.66B
stocks logo
PCVX.O
Vaxcyte Inc
loss
42.50%
9.27B
stocks logo
HALO.O
Halozyme Therapeutics Inc
12.64
62.91%
7.67B
stocks logo
SMMT.O
Summit Therapeutics Inc
loss
-59.16%
5.52B
stocks logo
ILMN.O
Illumina Inc
18.65
13.56B

TECH Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition (FY2024Q4)
Name
Revenue
Percentage
Consumables
245.78M
80.29%
Instruments
27.09M
8.85%
Service
28.18M
9.21%
Royalty
5.05M
1.65%

TECH FAQs

Is TECH currently overvalued based on its P/E ratio?

According to the provided data, TECH's 5-year historical average forward P/E ratio is 44.77. TECH forward P/E ratio is 29.44, which is categorized as Undervalued.

How has TECH's P/E ratio changed over the quarters?

What is the significance of the EV/EBITDA ratio for TECH?

How has TECH's Price to Sales (PS) ratio evolved?

What are the key indicators to watch for TECH's financial performance?

TECH PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Undervalued
5Y Average PE
44.77
Current PE
29.44
Overvalued PE
54.06
Undervalued PE
35.48

TECH EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Undervalued
5Y Average EV
31.21
Current EV
21.66
Overvalued EV
37.29
Undervalued EV
25.13

TECH P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Undervalued
5Y Average PS
11.78
Current PS
7.46
Overvalued PS
14.56
Undervalued PS
9.01

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is TECH undervalued?Is TECH overvalued compared to its competitors?